17-45024489-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001288655.2(DCAKD):c.640G>A(p.Ala214Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000517 in 1,613,220 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001288655.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000307 AC: 77AN: 251132Hom.: 0 AF XY: 0.000273 AC XY: 37AN XY: 135766
GnomAD4 exome AF: 0.000545 AC: 797AN: 1461100Hom.: 0 Cov.: 32 AF XY: 0.000519 AC XY: 377AN XY: 726684
GnomAD4 genome AF: 0.000243 AC: 37AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.640G>A (p.A214T) alteration is located in exon 5 (coding exon 4) of the DCAKD gene. This alteration results from a G to A substitution at nucleotide position 640, causing the alanine (A) at amino acid position 214 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at